Next Science Limited
ASX:NXS.AX
0.155 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 16.849 | 18.494 | 14.97 | 9.408 | 7.528 | 6.88 | 5.075 | 3.303 | 1.605 | 2.506 | 3.322 | 1.449 |
| Cost of Revenue
| 3.407 | 4.969 | 5.648 | 3.114 | 1.912 | 1.599 | 1.086 | 1.037 | 6.836 | 6.489 | 6.487 | 0.196 |
| Gross Profit
| 13.442 | 13.525 | 9.321 | 6.294 | 5.617 | 5.281 | 3.988 | 2.265 | -5.231 | -3.982 | -3.166 | 1.253 |
| Gross Profit Ratio
| 0.798 | 0.731 | 0.623 | 0.669 | 0.746 | 0.768 | 0.786 | 0.686 | -3.258 | -1.589 | -0.953 | 0.864 |
| Reseach & Development Expenses
| 5.003 | 4.786 | 4.978 | 4.7 | 4.176 | 3.466 | 3.255 | 6.786 | 1.598 | 1.016 | 1.468 | 0.618 |
| General & Administrative Expenses
| 4.807 | 4.371 | 3.951 | 3.063 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.772 |
| Selling & Marketing Expenses
| 13.045 | 16.23 | 13.668 | 8.263 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.232 |
| SG&A
| 17.852 | 20.628 | 16.585 | 10.683 | 10.633 | 9.095 | 6.283 | 3.247 | 3.707 | 3.783 | 4.606 | 4.004 |
| Other Expenses
| -0.624 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.72 |
| Operating Expenses
| 22.232 | 25.414 | 21.563 | 15.383 | 14.809 | 12.562 | 9.538 | 10.033 | 5.305 | 4.798 | 6.074 | 0.902 |
| Operating Income
| -8.79 | -11.889 | -12.241 | -9.089 | -9.193 | -7.281 | -5.55 | -7.768 | -10.535 | -8.781 | -9.24 | -4.371 |
| Operating Income Ratio
| -0.522 | -0.643 | -0.818 | -0.966 | -1.221 | -1.058 | -1.094 | -2.352 | -6.563 | -3.503 | -2.782 | -3.017 |
| Total Other Income Expenses Net
| 0.031 | 0.152 | -0.509 | -0.01 | 0.026 | 0.24 | 0.107 | 0.551 | 0.337 | -2.574 | -0.079 | -0.75 |
| Income Before Tax
| -8.759 | -11.737 | -12.75 | -9.099 | -9.167 | -7.041 | -5.443 | -7.218 | -10.198 | -11.355 | -9.319 | -5.121 |
| Income Before Tax Ratio
| -0.52 | -0.635 | -0.852 | -0.967 | -1.218 | -1.023 | -1.073 | -2.185 | -6.353 | -4.53 | -2.805 | -3.534 |
| Income Tax Expense
| -0 | 0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0.75 |
| Net Income
| -8.759 | -11.737 | -12.75 | -9.099 | -9.167 | -7.041 | -5.443 | -7.218 | -10.198 | -11.355 | -9.319 | -5.871 |
| Net Income Ratio
| -0.52 | -0.635 | -0.852 | -0.967 | -1.218 | -1.023 | -1.073 | -2.185 | -6.353 | -4.53 | -2.805 | -4.052 |
| EPS
| -0.03 | -0.045 | -0.059 | -0.042 | -0.045 | -0.036 | -0.028 | -0.037 | -0.056 | -0.063 | -0.061 | -0.035 |
| EPS Diluted
| -0.03 | -0.045 | -0.059 | -0.042 | -0.045 | -0.036 | -0.028 | -0.037 | -0.056 | -0.063 | -0.061 | -0.035 |
| EBITDA
| -7.89 | -10.997 | -11.455 | -8.261 | -8.716 | -6.846 | -5.174 | -7.273 | -10.012 | -8.336 | -8.87 | -4.17 |
| EBITDA Ratio
| -0.468 | -0.595 | -0.765 | -0.878 | -1.158 | -0.995 | -1.02 | -2.202 | -6.237 | -3.326 | -2.671 | -2.878 |